NCT07244276 Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery
| NCT ID | NCT07244276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Eye Hospital |
| Condition | Primary Pterygium |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2026-04-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-04-02 with a primary completion date of 2026-04-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the advantages and disadvantages of continuous suture with suture and conventional Suture in primary pterygium surgery for autologous conjunctival graft fixation
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of primary pterygium according to diagnostic criteria; 2. The pterygium head invades the cornea by 2-5mm; 3. The patient agrees to the surgical treatment and signs the surgical consent form. Exclusion Criteria: 1. History of previous eye surgery; 2. Have active ocular inflammatory lesions; 3. recurrent and pseudopterygium; 4. The patient refuses surgery or is unable to have regular follow-ups
Contact & Investigator
Yi Zhang
STUDY DIRECTOR
Tianjin Eye Hospital
Frequently Asked Questions
Who can join the NCT07244276 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 70 Years, studying Primary Pterygium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244276 currently recruiting?
Yes, NCT07244276 is actively recruiting participants. Contact the research team at wangyan7143@vip.sina.com for enrollment information.
Where is the NCT07244276 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07244276 clinical trial?
NCT07244276 is sponsored by Tianjin Eye Hospital. The principal investigator is Yi Zhang at Tianjin Eye Hospital. The trial plans to enroll 40 participants.